ArticleItalian journal of pediatrics2025
Predictive value of the combined evaluation of the neutrophil-to-lymphocyte ratio and lactate dehydrogenase level for coronary artery lesions in patients with acute Kawasaki disease.
Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lactate dehydrogenase-to-albumin ratio as a predictor of coronary artery lesions in Kawasaki disease.Translational pediatrics · 2026Article
- Early prediction of severe autoimmune encephalitis: development and validation of a model incorporating readily available lactate dehydrogenase.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe objective of this research was to explore the predictive value of the combination of the neutrophil-to-lymphocyte ratio (NLR) and lactate dehydrogenase level for coronary artery lesions (CAL) in patients with acute Kawasaki disease (aKD).
methodsWe retrospectively reviewed a total of 215 patients diagnosed with aKD. Patients were divided into two groups according to their CAL: aKD patients without CAL (n = 134) and those with CAL (n = 81). We compared the differences in age at diagnosis, sex, and laboratory and echocardiography data between the two groups. Multivariate logistic regression analysis was performed to evaluate the risk factors for predicting CALs in patients with aKD. Receiver operating characteristic (ROC) curve analysis was performed to detect the sensitivity and specificity of the NLR, LDH, and the combination of the two values in patients with CAL with aKD.
resultsPLT, ALB, LDH, CK, and CK-MB in aKD patients without CAL were significantly greater than those in patients with CAL, whereas hs-CRP and TBIL were significantly lower than those in patients with CAL (P < 0.05). Echocardiography data showed that LCAd, RCAd, LVDd, IVSd, and LVPWd were significantly greater in aKD patients with CAL than in those without CAL (P < 0.05). After adjusting for age at diagnosis, sex, LDH, CK, IVSd, LVPWd, LVDd, and LVEF, NLH remained an independent risk indicator related to CAL (OR: 1.210, 95% CI: 1.0221.432, P = 0.027). ROC analysis revealed that LDH demonstrated excellent sensitivity (90.28%), whereas the NLR showed excellent specificity (91.79%). The combined evaluation exhibited good sensitivity (52.78%), specificity (80.30%), and AUC (0.727, 95% CI: 0.660 to 0.787); these findings indicate that the combined assessment is superior to the single-index assessment using the NLR (P Combination vs. NLR = 0.007).
conclusionThe present research concluded that NLH is an independent risk indicator related to CAL in aKD patients. When the NLR is > 4.06 and/or LDH is < 370.4 U/L, aKD patients are more likely to develop CAL. The combination of NLR and LDH level has good predictive value for CAL in aKD patients. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.